When you might want both.

• Forehead lines + flat temples. Botox for the lines, filler for the temple hollow.
• Crow's feet + flat cheeks. Botox for the lines, filler in the upper cheek.
• Jaw slimming + chin projection. Botox in the masseter, filler in the chin.

"They don't compete. They do different things. Most clinics know this, and will still try to sell you both for the wrong reasons."

When neither is the right answer.

• Sagging skin or jowls. You need lifting (Ulthera, Thermage, threads, or surgery), not injectables.
• Dark circles from pigmentation (not hollows). Needs laser or topical treatment, not filler.
• Significant volume loss across the whole face. Fat grafting is more cost-effective long-term than six-plus syringes of filler.

Scenarios where the answer flips.

The decision is rarely the abstract one. Five realistic starting points and the version of the answer that actually applies.

• "I'm 26, never had work done, want a subtle change." Default to neither for one more year. If you must, two units of Botox in the glabella beats any first syringe of filler. The "tweakment" floor is younger than it should be; resist the salon-grade upsell.
• "I'm 32, my under-eye looks tired even after sleep." If the cause is true hollowing, a very conservative 0.3 to 0.5cc of cohesive HA in the tear trough by an injector who refuses you when the cause is pigmentation. Botox does nothing here.
• "I'm 40, lines on my forehead that don't go away." Botox first, in low units, and reassess at six weeks. If lines persist at rest, a small amount of HA placed superficially can soften the static groove, but only after the muscle is quieted.
• "I'm 48, my lower face is sliding." Neither product is the right answer. This is laxity, not volume; you want HIFU, threads, or surgical assessment. Filler in the cheek to "lift the jowl" is the most-regretted use of filler in patients over 45.
• "I had filler three years ago, my face looks puffier than it should." Probable migrated or accumulated HA. The right next step is hyaluronidase dissolution, not more filler, not Botox.

Long-term thinking: 5, 10, and 20 years.

• 5 years of regular Botox. Trained-in restraint. Muscles you stop using atrophy slightly; some patients find they need fewer units to maintain the same effect.
• 5 years of regular filler. Some HA persists longer than the brochures suggest. Imaging studies show residual product at four to five years in some patients. The "lasts six months" figure is the cosmetic effect, not the molecule.
• 10 years of regular Botox. Possible antibody formation in a small percentage; reduced response to the same dose. Rotating brand or taking a year off is a reasonable hedge.
• 10 years of regular filler. Accumulation becomes visible in patients who never stopped. The face reads "filler face" rather than "ageing face." Periodic hyaluronidase resets are increasingly standard.
• 20 years of either. Most patients will have shifted to a maintenance protocol that mixes both with energy devices and, for many, eventual surgical refresh. The plan that starts at 30 is not the plan that ends at 55.

The cost-adjusted decision.

The sticker price hides the math that actually matters: how much you spend over five years to keep the result.

• Botox, three areas, every four months. $900 to $1,500 per year. Five-year total: roughly $5,000 to $7,500.
• Lip filler, 0.5 to 1cc, every nine months. $400 to $700 per visit. Five-year total: roughly $2,700 to $4,500.
• Cheek filler protocol, 2cc, every 18 months. $800 to $1,400 per visit. Five-year total: $2,400 to $4,500.
• Fat grafting, single staged protocol. $6,000 to $10,000 once. Surviving fat permanent; refresh maybe at year 5 to 7. Often cheaper than 5+ years of equivalent filler.

The number that should drive the decision is not "what does this cost today" but "what will my face cost to keep at year five." Filler-maximalists frequently spend more, over a longer period, than they would have on a planned surgical or fat-grafting strategy.

What the marketing won't tell you.

• About Botox. "Brow heaviness" is a real and under-disclosed side effect when forehead muscle is over-quieted without compensation. Treatment requires technique, not just product.
• About filler. Some HA formulations migrate. Lips and tear troughs are the highest-migration areas. Imaging at year three frequently shows product where it was not placed.
• About both. The "natural" first visit becomes the baseline against which "more" is later judged. Maintenance dose creep is the most predictable feature of long-term aesthetic medicine.
• About neither. A great skincare routine, sleep, sun protection, and one annual energy device session frequently outperform a year of low-grade injectables for patients under 40.